Inhibition of constitutive protein secretion from lactating mouse mammary epithelial cells by FIL (feedback inhibitor of lactation), a secreted milk protein.
The effect of a protein feedback inhibitor of lactation (FIL) on casein synthesis and secretion was examined using isolated acini from lactating mouse mammary gland. As previously found, FIL partially inhibited protein synthesis but produced an additional inhibition of constitutive casein secretion. The inhibition of synthesis and secretion showed similar dose-dependency and the inhibition was fully reversible. Constitutive secretion of pre-formed protein was inhibited by FIL in a pulse-chase protocol, indicating that the inhibitor regulated protein secretion by reducing protein movement through the secretory pathway independently of any initial inhibition of synthesis. Regulated exocytosis was not inhibited since casein release due to elevation of cytosolic Ca2+ concentration by the ionophore ionomycin was unaffected. Brefeldin A, which is known to block ER-to-Golgi transport, also inhibited both protein synthesis and secretion in mammary cells. The action of FIL on synthesis and secretion and previously described actions on casein degradation would be consistent with a block at an early stage in the secretory pathway. In support of this idea FIL treatment was found to result in vesiculation and swelling of the endoplasmic reticulum. These data provide evidence for a novel control of a constitutive secretory pathway by a physiological extracellular regulatory protein.
Rennison
M E
ME
Physiological Laboratory, University of Liverpool, UK.
Kerr
M
M
Addey
C V
CV
Handel
S E
SE
Turner
M D
MD
Wilde
C J
CJ
Burgoyne
R D
RD
D000818:Animals; D020126:Brefeldin A; D002364:Caseins / Q000096:biosynthesis / Q000378:metabolism*; D003517:Cyclopentanes / Q000494:pharmacology; D004721:Endoplasmic Reticulum / Q000187:drug effects / Q000648:ultrastructure; D005089:Exocytosis / Q000187:drug effects; D005246:Feedback; D005260:Female; D006056:Golgi Apparatus / Q000187:drug effects / Q000648:ultrastructure; D066298:In Vitro Techniques; D007774:Lactation / Q000502:physiology; D008321:Mammary Glands, Animal / Q000187:drug effects* / Q000378:metabolism*; D051379:Mice; D008854:Microscopy, Electron; D008894:Milk Proteins / Q000378:metabolism* / Q000494:pharmacology*; D011247:Pregnancy
D002364:Caseins; D003517:Cyclopentanes; D008894:Milk Proteins; D020126:Brefeldin A